Form 4 Tracker
Max Rosett

Chief Financial Officer · 1 filing · Latest: Apr 2, 2026

Immunome Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
IMNM
Max RosettChief Financial OfficerApr 2, 2026
Sale
$21.9265,000$1.4M54,037
IMNM
Max RosettChief Financial OfficerApr 2, 2026
Option Exercise
$1.2271,561$87.1K119,037
Max Rosett — Insider Trading Activity | Form 4 Tracker